Skip to main content

Nonprofit · EIN 26-1990525

CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION

Tax-exempt · HOUSTON, TX 77005

Financials

$15K$3K2021
Revenue Expenses · by fiscal year end
Financials of CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2021990-EZ$14,595$3,012$11,583$68,735–$68,735
Financial details: 990-EZ for the year ended December 31, 2021

Revenue

Program service revenue
$14,595

Expenses

Compensation of officers, directors and key employees
$0
Other expenses
$3,012

Balance sheet and other

Total assets, start of year
$57,152
Total assets, end of year
$68,735
Total liabilities, end of year
–
Net assets, end of year
$68,735
Cash, savings and investments
$68,735
Gross receipts
$14,595

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990-EZ for the year ended December 31, 2021, highest compensation first.

NameTitleHours / weekCompensation
Dr Peter HoughtonPresident0.5$0
Dr Robert KramerVice-President0.5$0
Dr James WinkerSecretary0.5$0
Dr William PlaczekTreasurer0.5$0
Dr Mary-Ann BjornstiBoard Member0.5$0
Dr Philip A DennisBoard Member0.5$0
Dr Martin McMahonBoard Member0.5$0
Dr Eli WallaceBoard Member0.5$0
Dr Lori FriedmanBoard Member0.5$0
Dr Zahid SiddikBoard Member0.5$0
Dr Bob AbrahamBoard Member0.5$0

Address and contacts

Address (IRS master file)
2455 DUNSTAN RD APT 227, HOUSTON, TX 77005-2304
In care of
% WILLIAM PLACZEK
Mailing address (990-N for 2025)
2455 Dunstan Road227, Houston TX 77005
Principal officer (990-N for 2025)
Aria Vaishnavi, 2455 Dunstan Road, 227, Houston TX 77005
Signed the 990-EZ
William J Placzek, Treasurer

Mission

To host a scientific conference

990-EZ for the year ended December 31, 2021

Program accomplishments

  • Due to Covid19 we did not host a conference this year and all activities were in preparation for the 2022 Conference

What it must file and when

IRS records say it files Form 990-N (e-Postcard). Gross receipts normally $50,000 or less. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990-N on file
2024December 31, 2024May 15, 2025990-N on file
2023December 31, 2023May 15, 2024Check at the IRS

IRS record

EIN
26-1990525
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2008
Accounting year ends
December
Files
Form 990-N (e-Postcard)

Filing history

FormYear endedRevenueExpensesAssetsReturn
990-N for 2025
Officer: Aria Vaishnavi
December 31, 2025≤ $50,000 receipts––e-Postcard
990-N for 2024
Officer: William J Placzek
December 31, 2024≤ $50,000 receipts––e-Postcard
990-EZDecember 2021$14,595$3,012$68,735XML

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 26-1990525).

Questions about CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION

What is the EIN of CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION?
The employer identification number (EIN) of CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION is 26-1990525.
Is CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2008.
Are donations to CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION file?
Form 990-N (e-Postcard). Gross receipts normally $50,000 or less.
When is the next return of CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION last file with the IRS?
The latest return in the IRS public files is the 990-N for 2025 for the year ended December 31, 2025.
Who is the principal officer of CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION?
The 990-N for 2025 names Aria Vaishnavi.
Who are the officers and directors of CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION?
The 990-EZ for the year ended December 31, 2021 lists 11 people; 0 received compensation from the organization.
How much revenue does CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION have?
On its 990-EZ for the year ended December 31, 2021 it reported revenue of $14,595, expenses of $3,012 and total assets of $68,735 at year end.

Other nonprofits in HOUSTON

All nonprofits in HOUSTON · Texas · Voluntary health associations and medical disciplines